Shenzhen Chipscreen Biosciences Co., Ltd.

Chinese biotech developing original small-molecule drugs for cancer and diabetes

What Shenzhen Chipscreen Biosciences does

Chipscreen Biosciences is a Shenzhen drug developer that discovers and develops its own small-molecule medicines. Its main drugs are Chidamide, used for certain lymphomas and breast cancer, and Chiglitazar, used for type 2 diabetes. Its pipeline also includes candidates for cancer, immune diseases and hepatitis B.

How Shenzhen Chipscreen Biosciences makes money

It makes money by manufacturing and selling its own drugs in China, mainly Chidamide and Chiglitazar. It also spends heavily on research to bring new pipeline drugs to market.

Products & services

• Chidamide (HDAC inhibitor for lymphoma and breast cancer)
• Chiglitazar (PPAR agonist for diabetes)
• Cioronib (multi-target kinase inhibitor for cancer)
• CS23546 (oral small-molecule PD-L1 inhibitor)
• CS12192 (selective JAK3 inhibitor)
• CS12088 (hepatitis B capsid assembly modulator)